Interplay Between KLF4 and ZEB2/SIP1 in the Regulation of E-cadherin Expression
Overview
Affiliations
E-cadherin expression is repressed by ZEB2/SIP1 while it is induced by KLF4. Independent data from the literature indicate that these two transcription factors could bind close to each other in the proximal region of the E-cadherin gene promoter. We have here explored a potential competition between ZEB2 and KLF4 for the binding to the E-cadherin promoter. We show an inverse correlation between ZEB2 expression levels and KLF4 recruitment on the E-cadherin promoter in three breast cancer cell lines and in A431/HA.ZEB2 cells in which ZEB2 expression is induced by doxycycline (DOX). We identified a region of the E-cadherin promoter bound by KLF4 which is necessary for the activation of the E-cadherin promoter activity after KLF4 overexpression. This region is localized between positions -28 and -10 and thus overlaps with one of the ZEB2 binding sites. Deleting the bipartite ZEB2 binding site results in increased KLF4 induced E-cadherin promoter activity. Taken together, our results suggest that E-cadherin expression in cancer cells is controlled by a balance between ZEB2 and KLF4 expression levels.
Ingruber J, Dudas J, Savic D, Schweigl G, Steinbichler T, Greier M Exp Cell Res. 2022; 414(1):113084.
PMID: 35219646 PMC: 7613960. DOI: 10.1016/j.yexcr.2022.113084.
Zhang Z, He X, Xu J, Zhang G, Yang Y, Ma J J Gastric Cancer. 2020; 20(2):212-224.
PMID: 32596004 PMC: 7311212. DOI: 10.5230/jgc.2020.20.e19.
Agbo K, Huang J, Ghaleb A, Williams J, Shroyer K, Bialkowska A J Cancer Metastasis Treat. 2020; 5.
PMID: 32566755 PMC: 7304562. DOI: 10.20517/2394-4722.2019.35.
Kong F, Sun T, Kong X, Xie D, Li Z, Xie K Clin Cancer Res. 2018; 24(10):2440-2451.
PMID: 29367428 PMC: 6765216. DOI: 10.1158/1078-0432.CCR-17-3346.
Li X, Zhao Z, Zhang X, Yang S, Lin X, Yang X Oncotarget. 2017; 8(55):93924-93941.
PMID: 29212199 PMC: 5706845. DOI: 10.18632/oncotarget.21370.